Astraznica’s CEO in Israel cools the enthusiasm and declares: We have managed to produce a dedicated channel for Israel that meets all regulations within these time frames. We will make every effort to get it as soon as possible, but it is very difficult to commit to these things.
While theA representative of the Modern Company announced on Sunday that citizens of the United States will be able to be vaccinated within 24 hours from the moment the vaccine is approved. And in about 20 days the citizens of the United States will start receiving the vaccine, at Astraznica things are a bit tiring
Following the company’s announcement yesterday that the corona vaccine has been proven to be 90% effective, Ohad Goldberg, CEO of Astraznica Israel, told Niv Raskin this morning (Tuesday) on N12’s Morning News’ program that Astraznica vaccines will arrive in Israel only in mid-May-June. Summer. “Right now at the end of the first half which is May-June. Astrazenica produces a very large array that works on a global and as egalitarian distribution as possible. We have succeeded in producing a dedicated channel for Israel that meets all regulations within these time frames. We will make every effort to get it as early as possible, but it is very difficult to commit to these things and we do not come out with speculations and statements that we cannot meet. “
Goldberg explained the meaning of the delay. Regulation. Astrazenica will work with the FDA, EMA and regulatory authorities around the world to make sure it passes as cleanly as possible.
“Astrazenica has the potential to produce three billion vaccines. This is the widest production of vaccines ever in such a short period of time. We will bring ten million vaccines to Israel from the end of the first half, that’s the good news. We will try to get as early as possible. Immigrants and immigrants, “Goldberg added.
Goldberg, in addition to polls published in which it was claimed that over 50% of the public feared the vaccines, stated that he would not take the vaccine, saying “our safety profile is very good. There are no hospitalizations and no side effects related to the vaccine. There are 50,000 trials worldwide and no cases of disease. “Among those who received the vaccine, these are unprecedented things in such large trials. We wanted to make sure there was no possibility of a safety issue. We stand behind it.”
“In the world of vaccines, 90% is unprecedented. All vaccines are very important, from the beginning we have wished success to everyone, including Pfizer and Modern. The game is not between vaccines but all vaccines will come as soon as possible. We are in a paralyzed world and the pharmaceutical industry has a huge mission to get us out of the situation. This one, “Goldberg said at the conclusion, referring to the efficiency percentages of Astraznica, which are a few percent lower than the competition.